Zbliżenie na sprawdzanie poziomu glukozy glukometrem

Type 2 Diabetes: How Treatment Looks From Diagnosis — Step by Step

Q: Does every patient with type 2 diabetes have to start medication right away?

Under current ADA guidelines, in most patients pharmacological treatment, most often metformin, starts alongside lifestyle change right from the moment of diagnosis, rather than only after a trial of diet alone. An exception can be very mild hyperglycemia, where a doctor may decide on a short, closely monitored trial of lifestyle change alone — the decision is always made individually.

Q: Does metformin have serious side effects?

The most common are gastrointestinal complaints (nausea, diarrhea), which usually ease after a few weeks or with a slower dose increase. Long term, the drug is associated with a documented risk of reduced vitamin B12 levels, which we describe in more detail in a separate article — this risk is monitorable and doesn't disqualify the drug as first-line therapy.

Q: How does treating prediabetes differ from treating type 2 diabetes?

In prediabetes, the emphasis is mainly on intensive lifestyle change, and pharmacotherapy (mainly metformin) is sometimes considered selectively, e.g., in people with additional risk factors. In full-blown type 2 diabetes, pharmacological treatment is usually introduced right away, alongside lifestyle change.

Q: Can type 2 diabetes be reversed without medication, through diet alone?

The DiRECT trial showed that in some patients, especially early after diagnosis, intensive and substantial weight loss can lead to disease remission. This doesn't apply to every patient, though, and the decision to modify or discontinue medication should be made by a doctor based on results, never by the patient independently.

Q: Why do some patients get two drugs right from the start?

With very high HbA1c at diagnosis (well above target), some guidelines and doctors consider starting combination therapy right away, to reach the target glycemic control faster instead of waiting to assess the effectiveness of metformin alone after a few months.

Q: Do type 2 diabetes medications need to be taken for life?

For most patients, yes, since type 2 diabetes is a chronic, progressive condition, but in some people, especially after substantial and sustained weight loss, it's possible to reduce doses or discontinue some medications under medical supervision — never independently.

Q: How do SGLT2 inhibitors differ from GLP-1 agonists?

SGLT2 inhibitors lower blood glucose by increasing glucose excretion in urine and have documented benefit in heart failure and chronic kidney disease. GLP-1 receptor agonists work mainly by increasing glucose-dependent insulin secretion and slowing gastric emptying, with a clear weight-reduction effect and documented cardiovascular benefit in some patients.

Q: Is it worth self-monitoring blood glucose at home if not on insulin?

In patients treated only with drugs carrying low hypoglycemia risk (e.g., metformin alone), routine daily self-monitoring of blood glucose isn't always necessary, and the decision about how often to test is worth establishing individually with the treating physician, taking into account the treatment regimen and therapy goals.

A diagnosis of type 2 diabetes usually raises more questions than get answered in a single visit: where to start, whether medication is needed right away, what HbA1c level to aim for. We explain what standard management actually looks like today after diagnosis — from lifestyle change, through metformin as the first-choice drug, to situations where further drugs are added to treatment — in line with current American Diabetes Association guidelines.

PZdr Piotr ZielińskiSeptember 16, 202613 min read

Table of contents

TL;DR — key takeaways

→Diagnosed with type 2 diabetes — what happens next
→The foundation that stays throughout treatment: lifestyle
→Metformin — why it's still the first-choice drug
→When a second drug is added to metformin
→Insulin — when it's needed right away
→What the treatment targets are — HbA1c isn't the only number
→When to see a doctor urgently
→Summary in brief
→Our editorial recommendation

Diagnosed with type 2 diabetes — what happens next

Type 2 diabetes is diagnosed based on one of several laboratory criteria: fasting glucose ≥126 mg/dl, random glucose ≥200 mg/dl with accompanying symptoms, glycated hemoglobin (HbA1c) ≥6.5%, or an abnormal oral glucose tolerance test result — each of these, apart from a situation with overt hyperglycemia symptoms, usually requires confirmation with a repeat test. The diagnosis itself, however, isn't a moment when everything happens at once — it's a starting point for planning treatment tailored to the specific person, their other conditions, and their goals.

It's worth distinguishing type 2 diabetes from prediabetes, in which glucose levels are elevated but don't reach the diagnostic threshold for diabetes — there the approach is somewhat different and focuses primarily on intensive lifestyle change, before pharmacological treatment is even considered. In full-blown type 2 diabetes, current American Diabetes Association (ADA) guidelines recommend starting pharmacological treatment alongside lifestyle change right from the moment of diagnosis, rather than only after an unsuccessful attempt with diet and physical activity alone.

The foundation that stays throughout treatment: lifestyle

Lifestyle change — weight reduction in overweight or obesity, regular physical activity, limiting highly processed foods and simple sugars — remains the foundation of treatment for its entire duration, regardless of how many drugs get added later. This isn't a stage that "ends" once pharmacotherapy starts, but a parallel, permanent element of management.

Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial

Strong evidence

Lean ME, Leslie WS, Barnes AC et al. · The Lancet · 2018

A randomized clinical trial involving 306 people with type 2 diabetes diagnosed within the previous 6 years, conducted in a primary care setting. An intensive weight-loss program (a very-low-calorie diet with discontinuation of diabetes medication, followed by gradual reintroduction of regular meals) led to diabetes remission (HbA1c <6.5% without medication for at least 2 months) in 46% of participants after 12 months, versus 4% in the standard-care group. The probability of remission correlated strongly with the amount of weight lost — among those who lost ≥15 kg, 86% of participants achieved remission.

View study

The DiRECT trial matters for one reason: it shows that in some patients, especially early after diagnosis, an intensive, well-planned weight intervention can lead even to remission of the disease, not just improved glycemic control. This doesn't mean every patient should count on remission, or that pharmacotherapy is unnecessary while waiting for diet-related effects — in many people, both approaches are pursued in parallel from the very start.

Metformin — why it's still the first-choice drug

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024

Strong evidence

American Diabetes Association Professional Practice Committee · Diabetes Care · 2024

The official, annually updated ADA guidelines on pharmacotherapy for type 2 diabetes. They recommend metformin as the first-choice drug for most patients without contraindications, introduced together with lifestyle change from the moment of diagnosis. In people with established cardiovascular disease, chronic kidney disease, or heart failure, they recommend considering a drug with documented organ benefit (an SGLT2 inhibitor or a GLP-1 receptor agonist) regardless of baseline HbA1c, rather than only as a second-line drug after metformin failure.

View study

Metformin remains the first-choice drug for several reasons: well-documented efficacy in lowering blood glucose, decades of clinical experience, low cost, no risk of hypoglycemia when used as monotherapy, and a favorable or neutral effect on body weight compared with some other diabetes medications. The drug works mainly by reducing glucose production in the liver and improving tissue sensitivity to insulin.

A side effect worth knowing about from the start

Long-term metformin use is associated, as documented in several independent studies, with a risk of reduced vitamin B12 levels — a phenomenon whose mechanism and practical consequences we describe in detail in a separate article on metformin and vitamin B12 deficiency. This isn't a reason to avoid metformin, but it's a good argument for periodic B12 monitoring during long-term use.

When a second drug is added to metformin

The decision to add a second drug depends on two independent lines of reasoning. The first is glycemic control — if after about 3 months of metformin at the maximum tolerated dose, HbA1c doesn't reach the individual target, another drug is added, chosen based on the patient's profile (efficacy, hypoglycemia risk, effect on body weight, cost, preferences). The second, independent of the HbA1c level itself, is the presence of comorbidities with documented benefit from a specific drug class.

Clinical situation	Preferred drug class
Established cardiovascular disease or high risk	A GLP-1 receptor agonist or an SGLT2 inhibitor with documented cardiac benefit
Heart failure	An SGLT2 inhibitor
Chronic kidney disease	An SGLT2 inhibitor, often combined with a nonsteroidal mineralocorticoid receptor antagonist
Need for weight reduction as a priority	A GLP-1 receptor agonist or a dual GIP/GLP-1 agonist
Limited budget, no additional comorbidities	A sulfonylurea or other older-generation drugs, chosen individually

When adding a drug is considered regardless of baseline HbA1c

A shift in philosophy compared to the older approach

Strong evidence

Just over a decade ago, treatment of type 2 diabetes was almost entirely stepped based on HbA1c alone. Current ADA guidelines treat the presence of cardiovascular disease, heart failure, or chronic kidney disease as an independent signal for earlier introduction of a specific drug class — regardless of whether blood glucose itself is well controlled on metformin.

Insulin — when it's needed right away

In some patients, insulin therapy is needed right from the start, not only after other options have been exhausted — this applies especially to people with very high glucose at the time of diagnosis (e.g., HbA1c far above target, symptoms of overt hyperglycemia such as marked thirst and weight loss), or with features suggesting possible insulin deficiency. In such patients, short-term insulin treatment quickly brings glucose toxicity under control, after which some people can return to oral treatment.

In the typical course of type 2 diabetes, insulin is usually added later, when a combination of oral and non-insulin injectable drugs stops being sufficient to maintain the HbA1c target — which tends to be a natural consequence of the progressive decline, typical of this disease, in the pancreas's own insulin secretion over time.

Check your profile

Not sure which supplements actually make sense for you?

Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.

Takes about 2 minutesBased on scientific evidence

Find supplements for me

Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.

What the treatment targets are — HbA1c isn't the only number

Typical type 2 diabetes treatment targets (always individualized)

HbA1c <7% for most adults without significant comorbidities — a starting point, not a rigid rule for everyone
A less strict target (e.g., <8%) in older people, those with shorter life expectancy, or significant comorbidities where hypoglycemia risk outweighs the benefit of very tight control
Blood pressure and lipid control — just as important as glycemia itself for reducing cardiovascular risk
Weight reduction, when overweight or obesity coexists
Regular screening for complications: eye fundus, kidney function, foot sensation

When to see a doctor urgently

Symptoms requiring urgent evaluation

Intense thirst and passing very large amounts of urine accompanied by weakness and weight loss can signal significant hyperglycemia requiring urgent intervention. In people treated with insulin or sulfonylureas, symptoms of hypoglycemia — trembling, cold sweats, confusion, palpitations — require immediate intake of rapidly absorbed carbohydrates and, with recurring episodes, an urgent conversation with a doctor about adjusting the dose. Nausea, vomiting, abdominal pain, and rapid, deep breathing can be symptoms of diabetic ketoacidosis or a hyperglycemic hyperosmolar state — life-threatening conditions requiring immediate medical help.

Summary in brief

Question	Short answer
Does treatment start immediately after diagnosis?	Yes — lifestyle change and usually metformin are introduced in parallel from the moment of diagnosis
What's the first-choice drug?	Metformin, for most patients without contraindications
When is another drug added regardless of HbA1c?	With coexisting cardiovascular disease, heart failure, or chronic kidney disease
Is diabetes remission possible?	In some patients, mainly early after diagnosis, with substantial and sustained weight loss
What's the typical HbA1c target?	Below 7% for most adults, individualized based on age and comorbidities

Type 2 diabetes — treatment from diagnosis, in brief

Our editorial recommendation

The biggest mistake after a type 2 diabetes diagnosis is treating it as a single decision made once at the diagnostic visit, rather than a process requiring regular review — HbA1c checks every few months, updating treatment as new comorbidities appear, and consistent work on lifestyle alongside pharmacotherapy. Metformin as a starting point is a well-established decision, but what happens in the following months and years matters just as much for long-term prognosis.

Treating type 2 diabetes doesn't end with the metformin prescription written at diagnosis — that's only the beginning of a process that requires regular follow-up visits and a readiness to modify the plan as results change or new comorbidities appear.

dr Piotr Zieliński, VitMode editorial team

Frequently asked questions